REMEVi sits at No. 12 in our ranking with a Brief Score of 87. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.
Prefer a straight head-to-head? CoreAge Rx vs REMEVi.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
Fitish offers compounded semaglutide ($219/28 days) and compounded tirzepatide ($339/28 days) including consultation and shipping.
FDA warning letter, June 2026 — issued to FITISH. See the FDA's warning letter database.
A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.
Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.
Identical $199 pricing on both molecules, an oral route, LegitScript-certified and nationwide.
FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.
A LegitScript-certified, app-adjacent program with an oral option and mid-market pricing nationwide.
Goldspan Health charges $229 for compounded semaglutide and $299 for tirzepatide, billed every 28 days rather than monthly, which comes to 13 charges a year instead of 12.
HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.
Tru2u is a US direct-to-consumer telehealth and wellness store offering provider-guided compounded GLP-1 weight-loss therapy alongside hair, skincare, and supplement lines.
Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.